Private Label Tranexamic Acid SPF 50 Body Milk Low MOQ

Do I need FDA approval to sell a tranexamic acid SPF 50 body milk in the United States?

By Blake Mereby · Last reviewed October 3, 2026

Yes — in the United States, any leave-on product with an SPF claim is classified as an OTC (over-the-counter) drug by the FDA, regardless of whether it also has cosmetic properties like moisturising or brightening. This applies to your tranexamic acid SPF 50 body milk. You do not need pre-market approval in the traditional sense, but you must comply with the OTC drug monograph system, and the requirements are substantially more demanding than for a plain cosmetic.

First, the UV filters in your formula must appear on the FDA's approved OTC sunscreen monograph list. Filters approved for US use include avobenzone (up to 3%), octocrylene (up to 10%), octisalate (up to 5%), homosalate (up to 15%), oxybenzone (up to 6%), titanium dioxide (up to 25%), and zinc oxide (up to 25%). UV filters widely used in Europe and Asia — such as Tinosorb S, Tinosorb M, and Mexoryl XL — are NOT currently approved under the US monograph, meaning formulas built around these filters cannot be legally sold as sunscreens in the US without going through a New Drug Application (NDA), a multi-year, multi-million dollar process.

Second, manufacturing must occur in an FDA-registered OTC drug facility operating under 21 CFR Part 211 (pharmaceutical GMP), not merely ISO 22716 (cosmetic GMP). This is a critical distinction that disqualifies the majority of cosmetic contract manufacturers from producing SPF products for the US market.

Third, your product label must include a Drug Facts panel in the specific FDA-mandated format: active ingredients listed with their UV filter percentages, "Uses" (protects against sunburn), "Warnings" (including the skin cancer/skin aging alert), "Directions" (apply 15 minutes before sun exposure, reapply after 80 minutes of swimming/sweating), and "Inactive Ingredients" listed alphabetically.

Fourth, an in-vivo SPF test conducted according to the FDA's 2011 final rule protocol is required to substantiate your SPF 50 claim. In-vitro data alone is not sufficient for US market claims.

The tranexamic acid component has no specific FDA OTC drug classification; it is treated as a cosmetic inactive ingredient in this context. It does not require separate approval.

For founders new to the US sunscreen regulatory pathway, working with a manufacturer who already holds FDA OTC drug facility registration and has produced compliant SPF products is non-negotiable. AJ Cosmo Labs screens manufacturing partners for regulatory credentials — download the iOS app and filter for FDA OTC-registered facilities when posting your brief.

Ingredients in this answer: Tranexamic Acid · Titanium Dioxide · Octocrylene · Avobenzone · Homosalate

Read the full guide on Private Label Tranexamic Acid SPF 50 Body Milk Low MOQ →

More about Private Label Tranexamic Acid SPF 50 Body Milk Low MOQ

Tell us about your product

Tell us what you're selling and where. You can hire a vetted cosmetic chemist on AJ Cosmo Labs to review your formula and labeling. Starting is free.

Free to start · no credit card · continue in your browser or the iPhone app.

Have a product idea?

Connect with vetted cosmetic chemists and custom labs on AJ Cosmo Labs.

Get on the App Store Open the web app